Agram Pharmaceuticals LLP
About Agram Pharmaceuticals LLP
Data last updated:
Agram Pharmaceuticals LLP is a limited liability partnership (LLP) based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 June 2015 and has been in existence for over 11 years.
The LLP is registered with the Registrar of Companies (ROC), Delhi, under LLPIN AAE-1514. Its GSTIN is 07ABCFA7328N1Z6 (Delhi).
The LLP has a total obligation of contribution of ₹21 Lakh. It is led by designated partners Rajendra Kumar Verma and Chandra Kala Verma.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Unit No.1209 D – Mall Plot No. A1 Netaji Subhash Place Pitampura, Delhi, India – 110034.
As per MCA filings, the LLP has open charges of ₹7.81 Cr and satisfied charges of ₹53 Lakh on record.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressUnit No.1209 D – Mall Plot No. A1 Netaji Subhash Place Pitampura, Delhi, India – 110034
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Agram Pharmaceuticals LLP FY 2025 filings available
Financial Statement Summary of Agram Pharmaceuticals LLP
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Income | •••• | •••• | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• | •••• | •••• |
| Profit After Tax | •••• | •••• | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• | •••• | •••• |
| Assets and Liabilities | |||||
| Partners' Contribution | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Agram Pharmaceuticals LLP
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Agram Pharmaceuticals are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Designated Partners of Agram Pharmaceuticals LLP
Agram Pharmaceuticals has 2 designated partners on record. No former designated partners are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajendra Kumar Verma Also directs: Avizen Biopharma Private Limited, Astam Lifesciences Private Limited, VL Infratech Services Private Limited and 1 more | Designated Partner | 11 Jun 2015 | 11 Years 3 Months | Current |
| Chandra Kala Verma | Designated Partner | 11 Jun 2015 | 11 Years 3 Months | Current |
Charges & Borrowings of Agram Pharmaceuticals LLP
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Aug 2025 | United Bank of India | ₹5.81 Cr | Open |
| 30 Jan 2025 | Bank of Baroda | ₹2 Cr | Open |
| 05 May 2020 | State Bank of India | ₹53 Lakh | Satisfied |
Total charge records: 3 View all charges
Employees and EPFO Compliance at Agram Pharmaceuticals LLP
Employment history and EPFO contributions of people linked to Agram Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Agram Pharmaceuticals LLP
Designated partner changes at Agram Pharmaceuticals LLP
Agram Pharmaceuticals LLP has 2 designated partner changes on record since 2015: 2 appointments. The latest: Chandra Kala Verma was appointed as Designated Partner on 11 Jun 2015.
Credit Ratings, Litigation & Regulatory Alerts for Agram Pharmaceuticals LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Agram Pharmaceuticals LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Agram Pharmaceuticals LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Agram Pharmaceuticals LLP
Agram Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07ABCFA7328N1Z6 | Delhi | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Agram Pharmaceuticals LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Agram Pharmaceuticals LLP
Agram Pharmaceuticals is an active limited liability partnership based in Delhi, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 11 June 2015 (11+ years old) and is registered under LLPIN AAE-1514.
Agram Pharmaceuticals has 2 current designated partners:
- Rajendra Kumar Verma - Designated Partner
- Chandra Kala Verma - Designated Partner
The GSTIN of Agram Pharmaceuticals is 07ABCFA7328N1Z6, registered in Delhi.
The LLPIN (Limited Liability Partnership Identification Number) of Agram Pharmaceuticals is AAE-1514. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Agram Pharmaceuticals was incorporated on 11 June 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
Chandra Kala Verma was appointed as Designated Partner on 11 Jun 2015. Rajendra Kumar Verma was appointed as Designated Partner on 11 Jun 2015.
The registered office of Agram Pharmaceuticals is at Unit No.1209 D – Mall Plot No. A1 Netaji Subhash Place Pitampura, Delhi, India – 110034.
The total obligation of contribution is ₹21 Lakh.
Agram Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Agram Pharmaceuticals has open charges of ₹7.81 Cr and satisfied charges of ₹53 Lakh as per latest MCA filings.